Vaginal Cancer
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Vaginal Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Vaginal Cancer Local Doctors?
Elite in Vaginal Cancer
Elite in Vaginal Cancer

UPMC Magee-Womens Gynecologic Oncology

901 East Brady Street, Suite 100, 
Butler, PA 
Languages Spoken:
English, Thai
Accepting New Patients
Offers Telehealth

Dr. Sukumvanich is a specialized surgeon and gynecologic oncologist, specializing in the treatment of gynecologic and breast cancers. He serves as an assistant professor in the School of Medicine, and his research centers on the genetic causes of ovarian and breast cancers, and also cancer informatics (the science of analyzing large amounts of information). Dr. Sukumvanich is rated as an Elite provider by MediFind in the treatment of Vaginal Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Hysterectomy. Dr. Sukumvanich is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Sukumvanich is currently accepting new patients.

Elite in Vaginal Cancer
Radiation Oncology
Elite in Vaginal Cancer
Radiation Oncology

Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD 
Languages Spoken:
English
Offers Telehealth

Akila Viswanathan, M.D., M.P.H., is the director for the Department of Radiation Oncology and Molecular Radiation Sciences, and a professor of radiation oncology, gynecology/obstetrics and oncology for Johns Hopkins University School of Medicine. Dr. Viswanathan leads the department emphasizing excellence in clinical care, research and education. She has expertise with gynecologic cancers and their treatment, including cervical and uterine cancers and image-guided brachytherapy. She has developed numerous clinical innovations and initiated several system-wide integration efforts at all sites, including Green Spring Station, Bayview, Johns Hopkins Hospital, Suburban's Rockledge site, and Sibley Memorial Hospital for the Johns Hopkins Department of Radiation Oncology. Dr. Viswanathan earned her undergraduate degree at Harvard University, her medical degree at the University of Pittsburgh School of Medicine, followed by her Masters in Public Health and Masters in Epidemiology at the Harvard School of Public Health. She completed a residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School, where she served as chief resident. She has had research grant funding through the National Cancer Institute K07, R21 and R01 programs to support efforts in gynecologic cancers, specifically looking at the identification of gynecologic tumors at the time of brachytherapy under magnetic resonance imaging. The research team has developed several novel clinical innovations. Dr. Viswanathan has been named one of America's Top Doctors by Newsweek, Who’s who in America, and a Super Doctor by the Washington Post magazine. Dr. Viswanathan served as President and Chair of the Board of the American Brachytherapy Society; Chair of Education Committee for American Society for Radiation Oncology; and, on the Gynecologic Cancer Steering Committee and the uterine cancer task force for the National Cancer Institute. Dr. Akila Viswanathan has published more than 200 articles and chapters, and lectures nationally and internationally. She is the Editor-in-Chief for Seminars in Radiation Oncology. She is on the editorial board of Gynecologic Oncology and Brachytherapy, and is an editor of several textbooks including Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management, Radiation Therapy Techniques for Gynecologic Cancers, and Gunderson and Tepper's Clinical Radiation Oncology. Make A Gift. Dr. Viswanathan is rated as an Elite provider by MediFind in the treatment of Vaginal Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Vaginal Cancer, Cervical Cancer, Vulvar Cancer, Vulvectomy, and Cordotomy. Dr. Viswanathan is board certified in American Board Of Radiology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Vaginal Cancer
Radiation Oncology
Elite in Vaginal Cancer
Radiation Oncology

UPMC Hillman Cancer Center

300 Halket Street, 
Pittsburgh, PA 
Languages Spoken:
English
Accepting New Patients

John Austin Vargo IV, MD, is a radiation oncologist specializing in breast cancer and gynecologic malignancies, including image-based brachytherapy and stereotactic radiotherapy. Dr. Vargo is rated as an Elite provider by MediFind in the treatment of Vaginal Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Vaginal Cancer, Cervical Cancer, Endometrial Cancer, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery. Dr. Vargo is board certified in American Board Of Radiology. Dr. Vargo is currently accepting new patients.

What are the Latest Advances for Vaginal Cancer?
What are the latest Vaginal Cancer Clinical Trials?
Phase II Basket Study to Evaluate the Tissue-agnostic Efficacy of Anti-Programmed Cell Death Protein 1 (Anti-PD1) Monoclonal Antibody in Patients With Advanced Rare Tumors

Summary: The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardless of the tumor's tissue type or location. Patients who have not responded to standard treatments will be included, and ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I Study of Pomalidomide and Nivolumab in Patients With Virus-Associated Malignancies With or Without HIV

Background: Less toxic and more effective treatments are needed for cancers caused by viruses. These cancers include Hodgkin and non-Hodgkin lymphoma, hepatocellular carcinoma, head and neck cancer, nasopharyngeal carcinoma, gastric cancer, anal cancer, cervical cancer, vaginal cancer, vulvar cancer, penile cancer, Merkel cell carcinoma, Kaposi sarcoma, and leiomyosarcoma. Researchers want to see if a combina...